Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

5.6%

8 terminated/withdrawn out of 144 trials

Success Rate

89.9%

+3.4% vs industry average

Late-Stage Pipeline

10%

15 trials in Phase 3/4

Results Transparency

8%

6 of 71 completed trials have results

Key Signals

33 recruiting6 with results5 withdrawn

Enrollment Performance

Analytics

N/A
66(68.0%)
Phase 3
13(13.4%)
Phase 2
10(10.3%)
Phase 1
6(6.2%)
Phase 4
2(2.1%)
97Total
N/A(66)
Phase 3(13)
Phase 2(10)
Phase 1(6)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (144)

Showing 20 of 144 trials
NCT06931938Not ApplicableRecruiting

Awake Prone Positioning in Spontaneous Breathing Patients With Acute Hypoxic Respiratory Failure Due to Pneumonia

Role: collaborator

NCT07561255Not ApplicableRecruiting

Exploratory Investigation of the Acceptance and Utility of 14-day Trial Periods and Application-related Outcome Measurement (AbEM) Within the Routine Prescription of the DiGA Axia.

Role: lead

NCT06416293Recruiting

Widening Aims and Giving Patients a Voice for Expanded Structures in Breast Cancer Care Jointly Developed by Patients and Physicians

Role: collaborator

NCT06792461Not ApplicableRecruiting

ePlatform for Promoting Health in Schools

Role: collaborator

NCT07553650Not Yet Recruiting

Master Study Protocol for the Cohort of the Specialist Network Stroke (SN Stroke)(Stroke-CORE)

Role: collaborator

NCT06576583Phase 2Recruiting

Implantation of Engineered Cartilage Grafts for Treatment of Patellofemoral Osteoarthritis Versus Surgical Comparators.

Role: collaborator

NCT06279793Phase 2Recruiting

Intravenous Fish Oil Based Lipid Emulsion to Enhance Recovery in High-Risk Cardiac Surgery Patients

Role: collaborator

NCT04225390Phase 2Completed

Preconditioning of Tumor, Tumor Microenvironment and the Immune System to Immunotherapy

Role: collaborator

NCT04075500Not ApplicableCompleted

Optimal Detection of Atrial Fibrillation in TIA

Role: collaborator

NCT06216158Phase 3Recruiting

Iberdomide vs. Iberdomide Plus Isatuximab Maintenance Therapy Post ASCT in Newly Diagnosed Multiple Myeloma

Role: collaborator

NCT01983748Phase 3Completed

Dendritic Cells Plus Autologous Tumor RNA in Uveal Melanoma

Role: collaborator

NCT07312760Not ApplicableRecruiting

Existential Distress in Advanced Cancer: Comparing a Short-term Psychodynamic Psychotherapy (ORPHYS) to Treatment as Usual (TAU)

Role: collaborator

NCT06920680Recruiting

ColoReg: A Register for Gastrointestinal Endoscopy Reports and Examination Videos

Role: lead

NCT07084480Recruiting

Giant Cell Arteritis - Ways to Precision Medicine

Role: lead

NCT03188796Phase 3Recruiting

The VITDALIZE Study: Effect of High-dose Vitamin D3 on 28-day Mortality in Adult Critically Ill Patients

Role: collaborator

NCT07212959Not ApplicableCompleted

As Part of a Pilot Study, Visualization of Inflammatory Activity in Systemic Sclerosis Using CXCR4 PET/CT

Role: lead

NCT05547919Not ApplicableRecruiting

PSMA in Gastroenterologic Tumors (GIPSMA)

Role: lead

NCT06931132Not ApplicableEnrolling By Invitation

Cancer-related Fatigue and Symptom Clusters - Effects of Virtual, Imagined and Real-life Nature-based Therapy in Cancer Survivors

Role: collaborator

NCT04917757Active Not Recruiting

Clinical Outcome of Autonomous Cortisol Secretion in Adrenal Incidentalomas

Role: lead

NCT07153289Phase 1Not Yet Recruiting

CD318-targeted CAR-T Cell Therapy in Patients With Pancreatic Cancer (ResCPa)

Role: collaborator